The FAST score has the strongest overall performance for identifying “at-risk” MASH, with magnetic resonance-based modalities offering reliable alternatives.

Deputy Secretary of HHS Jim O'Neill and General Counsel Mike Stuart will leave their posts amid changes meant to improve public messaging.

The FDA issued a refuse-to-file letter for Moderna’s mRNA-based flu vaccine amid a shift toward stricter scrutiny of mRNA technology.

President Trump terminated the EPA’s 2009 endangerment finding, ending federal authority to limit greenhouse gas pollution for public health.

California, Colorado, Illinois, and Minnesota filed a lawsuit against the Trump administration for rescinding over $600 million of funding.

The FDA has approved Optune Pax for the treatment of adult patients with locally advanced pancreatic cancer alongside gemcitabine and nab-paclitaxel.

Predictive testing and preventative treatment appealed to patients with inflammatory bowel disease and their family members.

Long-term low-dose aspirin use is associated with a significantly reduced risk for colorectal cancer and all-cause mortality among those with IBD.

Semaglutide treatment would be cost-effective at an annual price of $7,055 or less for adults with cardiovascular disease.

Most US adults with hypertension had uncontrolled blood pressure, and most of those adults were not taking antihypertensive medication.

Bismuth quadruple therapy is the most cost-effective first-line treatment for H pylori eradication. In the US, the rate of H pylori infection is 17.6%. The American College of Gastroenterology (ACG) ...

The US Department of Health and Human Services said it would rescind $600 million in public health funding from Democrat-led ...